Diversified Healthcare Trust Q3 2025 Earnings Recap

DHC Q3 2025 November 6, 2025

Get alerts when DHC reports next quarter

Diversified Healthcare Trust reported solid Q3 2025 results, with total revenue up 4% to $388.7 million. The transition of AlerisLife-managed communities presents challenges but aligns with long-term operational efficiency goals.

Earnings Per Share Miss

$0.04 vs $0.08 est.

-50.0% surprise

Revenue Miss

388706000 vs 392888670 est.

-1.1% surprise

Market Reaction

1-Day +4.58%

5-Day +7.4%

30-Day +13.51%

See DHC alongside your other holdings

Add to your portfolio — free

Key Takeaways

Adjusted EBITDAre was reported at $62.9 million; normalized FFO reached $9.7 million or $0.04 per share.
SHOP occupancy rose 210 basis points year-over-year to 81.5%, marking the fourth consecutive quarter of growth.
Temporary labor costs related to community transitions amounted to approximately $5.1 million, impacting NOI but expected to normalize in Q4.
A strategic wind-down of AlerisLife is underway, anticipated to generate $25 million to $40 million in net proceeds by 2026.
Medical Office and Life Science segment saw a 1.6% increase in same-property cash basis NOI, with consolidated occupancy improving to 86.6%.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit DHC on AllInvestView.